Kidney Cancer Association

We are pleased to present the Proceedings from the 2024 International Kidney Cancer Symposium (IKCS): Europe meeting, which we hosted this past April in Spain! Read it now and catch up on the key research presented at this premier #kidneycancer conference: https://bit.ly/3zZwCoQ Congratulations to the featured researchers on being accepted for publication! Thanks to Medicom Medical Publishers for this collaborative venture as well as our reviewers Drs. Lisa Pickering, Lars Lund, Gabriel Malouf, Ulka Vaishampayan, and Annika Fendler.

Final days to register for the 2024 IKCS: North America meeting, a leading scientific symposium for #kidneycancer! Register and join us in Louisville, KY next week! https://bit.ly/3OjTgfB

Today on #KidneyCancerUnfiltered, Raul Chavez, an 18-year kidney cancer survivor with an unclassifiable diagnosis, shares the emotional and mental toll of living life in three-month intervals, always wondering if he’ll receive a new lease on life with each #scan. He delves into the first five years of his journey, which he describes as being in "survivor mode," and the PTSD he endured after diagnosis. Raul’s story is a reminder of the impact of cancer beyond the physical and the challenges of long-term #survivorship. Raul’s full episode on Spotify, Apple Podcasts, or YouTube! https://lnkd.in/enMCymTC #unclassifiedRCC #YAC #cancersurvivor #ptsd #mentalhealth

📢 Exciting news for the kidney cancer research community!📢 Expand here 👇👇👇 We're proud to announce that the peer-reviewed Conference Proceedings from the 2024 IKCS: Europe Symposium have been published by Medicom Medical Publishers. Thank you to the reviewers: Lisa Pickering, Lars Lund, Gabriel Malouf, Ulka Vaishampayan, and Annika Fendler. Authors include: Ricky Frazer, Yüksel ÜRÜN, Fabien Moinard-Butot, Lijo James, James Blackmur. The proceedings feature key research findings and expert perspectives on topics presented at the symposium, including an important consensus views from the KCA Think Tank meeting on #digitalpathology, #moleculardiagnostics, and #biobanking in #renalcancer. This if the first of our series of Conference Proceedings that will accompany the IKCS Meetings. 📰 Explore the free articles online: https://lnkd.in/ePsDgQ3V #IKCSEU24 #RCC #KidneyCancer #MedicalResearch #KCA #Medicom #Conference #ConferenceProceedings #Oncology #RenalCancer #Research

Thank you to everyone who joined us for the KCA's 2024 Virtual Patient Symposium on September 21st! We hope you had a wonderful day of learning and connection. All the presentations are now available to watch on demand, go to: https://lnkd.in/eVmjdDTE #kidneycancer #education

Did you know we have a private group on Facebook dedicated to supporting individuals affected by #kidneycancer, including #patients, #caregivers, and #advocates? One member wrote: “I just wanted to thank everyone here you have all been a great help! This group is awesome.” 🧡 Managed and moderated by the KCA to ensure a safe and supportive environment for sharing experiences, seeking support, and offering encouragement. You can join here: https://lnkd.in/eC-GFsiD

Amy's journey with #cancer underscores the value of a strong support network. What's been your most significant source of support during challenging times? 🧡Family and Friends 🫂Online Support Groups 👩⚕️Healthcare Professionals 📝Personal Coping Strategies Comment the emoji below! #KidneyCancerUnfilteredPodcast #kidneycancer

We are excited to collaborate with @AACR and fellow advocacy orgs to support early-career #kidneycancer researchers! ✍️ Apply to the Scholars in Training Award: https://bit.ly/4fkX7E9 ❗ Applicants must be AACR members - apply (associate is free) by OCT 28 ❗ #AACRScholars

🚨 Attention Immunologists and Kidney Cancer Researchers: Apply Now for the CRI-KCA CLIP Grant! 🚨. Expand 👇👇👇 here for details The Cancer Research Institute (CRI) and the Kidney Cancer Association (KCA) have teamed up to drive groundbreaking kidney cancer immunotherapy research through the CRI-KCA CLIP Grant! 💡 This is your opportunity to lead transformative research in a field that impacts thousands of lives each year. 🌟 Why Apply? - 🔬 Focus on innovative immunotherapy for kidney cancer - 👥 Support preclinical and translational research - 🧬 Drive progress in early detection, side effect reduction, and improving patient quality of life - 💡 Collaboration across disciplines to fuel new discoveries With 14,390 projected deaths from kidney cancer in 2024, your research can make a real difference in improving survival rates and advancing treatment options. 💰 Grant Details: - Up to $300,000 over two years - Open to faculty holding a tenure-track or higher position - Letters of Intent due by December 1, 2024 - Funding begins July 1, 2025 Don’t miss this chance to make a lasting impact! 🌍🔬 📝 Learn more and apply: https://lnkd.in/gjsUGuHB #unstoppabletogether #CancerResearch #KidneyCancer #Immunotherapy #ResearchFunding #MedicalInnovation #ApplyNow

We chatted with Trailblazer Awardee Dr. Laura Bukavina about her research project to understand how microplastics and nanoplastics might accumulate in the kidneys - which filter all our blood of impurities - and potentially increase the risk of kidney cancer. Understanding environmental factors like this could help address prevention, treatment, and public health strategies in the future! #kidneycancer https://bit.ly/3C7KQnW